Drugs Made In America Acquisition Corp（DMAA）價格預測DMAADrugs Made In America Acquisition Corp

Alphio's DMAA stock price prediction model matches the current Drugs Made In America Acquisition Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.85 (-0.32%). The 1-week path is $11.02 (+1.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, DMAA is trading at $10.89, which is 97.5% of its 52-week high of $10.90. The RSI is at 59.42, indicating the asset is nearing overbought territory, which suggests caution. While the stock has shown a year-to-date change of +4.87%, the forward P/E is 0, indicating a lack of earnings growth expectations. The main risk is the current ratio of 0.02, suggesting potential liquidity issues.

Drugs Made In America Acquisition Corp (DMAA) last closed at $10.8800001, gaining +0.00%. These facts feed the 1-day and 1-week DMAA price prediction above.